These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2070501)

  • 81. The absorption and excretion of butylated hydroxyanisole in beagle dogs.
    Takizawa Y; Matsuda Y; Yamasita J
    Toxicol Lett; 1985 Sep; 27(1-3):27-34. PubMed ID: 4060184
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Synthesis and chemical carcinogen inhibitory activity of 2-tert-butyl-4-hydroxyanisole.
    Lam LK; Pai RP; Wattenberg LW
    J Med Chem; 1979 May; 22(5):569-71. PubMed ID: 458807
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Estimated daily intakes of butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT) and tert-butyl hydroquinone (TBHQ) antioxidants in Korea.
    Suh HJ; Chung MS; Cho YH; Kim JW; Kim DH; Han KW; Kim CJ
    Food Addit Contam; 2005 Dec; 22(12):1176-88. PubMed ID: 16356880
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Enhancement of BHA-induced proliferative rat forestomach lesion development by simultaneous treatment with other antioxidants.
    Hirose M; Masuda A; Tsuda H; Uwagawa S; Ito N
    Carcinogenesis; 1987 Nov; 8(11):1731-5. PubMed ID: 3664967
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Histopathological and radioautographical studies on the forestomach of F344 rats treated with butylated hydroxyanisole and related chemicals.
    Clayson DB; Iverson F; Nera E; Lok E; Rogers C; Rodrigues C; Page D; Karpinski K
    Food Chem Toxicol; 1986; 24(10-11):1171-82. PubMed ID: 3804119
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Lung hemorrhagic toxicity of butylated hydroxyanisole in the rat.
    Takahashi O; Sakamoto Y; Hiraga K
    Toxicol Lett; 1985 Sep; 27(1-3):15-25. PubMed ID: 4060183
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effects of simultaneous treatment with various chemicals on BHA-induced development of rat forestomach hyperplasia--complete inhibition by diethylmaleate in a 5-week feeding study.
    Hirose M; Inoue T; Masuda A; Tsuda H; Ito N
    Carcinogenesis; 1987 Oct; 8(10):1555-8. PubMed ID: 3115620
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The role of prostaglandin H synthase-mediated metabolism in the induction of oxidative DNA damage by BHA metabolites.
    Schilderman PA; van Maanen JM; ten Vaarwerk FJ; Lafleur MV; Westmijze EJ; ten Hoor F; Kleinjans JC
    Carcinogenesis; 1993 Jul; 14(7):1297-302. PubMed ID: 8330342
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Induction of forestomach lesions in rats by oral administrations of naturally occurring antioxidants for 4 weeks.
    Hirose M; Masuda A; Imaida K; Kagawa M; Tsuda H; Ito N
    Jpn J Cancer Res; 1987 Apr; 78(4):317-21. PubMed ID: 3108210
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Modification of N-methyl-N'-nitro-N-nitrosoguanidine-induced forestomach and glandular stomach carcinogenesis by phenolic antioxidants in rats.
    Hirose M; Fukushima S; Kurata Y; Tsuda H; Tatematsu M; Ito N
    Cancer Res; 1988 Sep; 48(18):5310-5. PubMed ID: 3409255
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effects of sodium nitrite and catechol, 3-methoxycatechol, or butylated hydroxyanisole in combination in a rat multiorgan carcinogenesis model.
    Hirose M; Tanaka H; Takahashi S; Futakuchi M; Fukushima S; Ito N
    Cancer Res; 1993 Jan; 53(1):32-7. PubMed ID: 8416747
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Induction of oxidative DNA damages and enhancement of cell proliferation in human lymphocytes in vitro by butylated hydroxyanisole.
    Schilderman PA; Rhijnsburger E; Zwingmann I; Kleinjans JC
    Carcinogenesis; 1995 Mar; 16(3):507-12. PubMed ID: 7697806
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Identification and structure characterization of S-containing metabolites of 3-tert-butyl-4-hydroxyanisole in rat urine and liver microsomes.
    Tajima K; Hashizaki M; Yamamoto K; Mizutani T
    Drug Metab Dispos; 1991; 19(6):1028-33. PubMed ID: 1687007
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A new metabolite of butylated hydroxyanisole in man.
    El-Rashidy R; Niazi S
    Biopharm Drug Dispos; 1983; 4(4):389-96. PubMed ID: 6661516
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Epigenetic promoting effects of butylated hydroxyanisole.
    Williams GM
    Food Chem Toxicol; 1986; 24(10-11):1163-6. PubMed ID: 3542763
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Oxygen radical formation during prostaglandin H synthase-mediated biotransformation of butylated hydroxyanisole.
    Schilderman PA; van Maanen JM; Smeets EJ; ten Hoor F; Kleinjans JC
    Carcinogenesis; 1993 Mar; 14(3):347-53. PubMed ID: 8384088
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Study of toxicity of butylated hydroxyanisole (BHA) in pregnant gilts and their foetuses.
    Hansen EV; Meyer O; Olsen P
    Toxicology; 1982; 23(1):79-83. PubMed ID: 7089986
    [TBL] [Abstract][Full Text] [Related]  

  • 98. DNA-adduct formation in the forestomach of rats treated with 3-tert-butyl-4-hydroxyanisole and its metabolites as assessed by an enzymatic 32P-postlabeling method.
    Saito K; Nakagawa S; Yoshitake A; Miyamoto J; Hirose M; Ito N
    Cancer Lett; 1989 Dec; 48(3):189-95. PubMed ID: 2514040
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Initiating activity of 3-tert-butyl-4-hydroxyanisole (3-BHA) and its metabolites in two-stage transformation of BALB/3T3 cells.
    Sakai A; Miyata N; Takahashi A
    Carcinogenesis; 1990 Nov; 11(11):1985-8. PubMed ID: 2225330
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Kinetics of 3-tert-butyl-4-hydroxyanisole (BHA) in man.
    Castelli MG; Benfenati E; Pastorelli R; Salmona M; Fanelli R
    Food Chem Toxicol; 1984 Nov; 22(11):901-4. PubMed ID: 6542057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.